These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 6833747)

  • 1. Vaccination against rubella and measles: quantitative investigations of different policies.
    Anderson RM; May RM
    J Hyg (Lond); 1983 Apr; 90(2):259-325. PubMed ID: 6833747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measles, mumps and rubella: control by vaccination.
    van Druten JA; de Boo T; Plantinga AD
    Dev Biol Stand; 1986; 65():53-63. PubMed ID: 3556777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous control of measles and rubella by multidose vaccination schedules.
    Becker NG; Rouderfer V
    Math Biosci; 1996 Jan; 131(1):81-102. PubMed ID: 8589539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling the Transmission of Measles and Rubella to Support Global Management Policy Analyses and Eradication Investment Cases.
    Thompson KM; Badizadegan ND
    Risk Anal; 2017 Jun; 37(6):1109-1131. PubMed ID: 28561947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of nationwide supplementary immunization in Lao People's Democratic Republic: Population-based seroprevalence survey of anti-measles and anti-rubella IgG in children and adults, mathematical modelling and a stability testing of the vaccine.
    Hachiya M; Miyano S; Mori Y; Vynnycky E; Keungsaneth P; Vongphrachanh P; Xeuatvongsa A; Sisouk T; Som-Oulay V; Khamphaphongphane B; Sengkeopaseuth B; Pathammavong C; Phounphenghak K; Kitamura T; Takeda M; Komase K
    PLoS One; 2018; 13(3):e0194931. PubMed ID: 29596472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative investigations of different vaccination policies for the control of congenital rubella syndrome (CRS) in the United Kingdom.
    Anderson RM; Grenfell BT
    J Hyg (Lond); 1986 Apr; 96(2):305-33. PubMed ID: 3701044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Epidemiologic study of measles, rubella and mumps with regard to the possibility of their control by immunization].
    Rodríguez Borrego MJ; García León J; Bolumar F; Nájera E
    Rev Sanid Hig Publica (Madr); 1985; 59(1-2):117-25. PubMed ID: 4059834
    [No Abstract]   [Full Text] [Related]  

  • 8. Measles and rubella vaccines.
    Dudgeon JA
    Arch Dis Child; 1977 Dec; 52(12):907-11. PubMed ID: 343722
    [No Abstract]   [Full Text] [Related]  

  • 9. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
    Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K
    N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination with a combined vaccine against measles, mumps and rubella aiming at elimination of the three diseases.
    Böttiger M; Christenson B; Strandell A; Romanus V
    Dev Biol Stand; 1986; 65():37-43. PubMed ID: 3556776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measles and rubella immunization. Statement of the Committe on Infectious Diseases, American Academy of Pediatrics.
    Postgrad Med; 1977 Jan; 61(1):269-72. PubMed ID: 834685
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prevalence of antibodies and vaccination against measles, mumps and rubella in Polish population].
    Janaszek-Seydlitz W; Bucholc B; Wysokińska T; Górska P; Gniadek G
    Przegl Epidemiol; 2003; 57(2):281-8. PubMed ID: 12910596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration of measles-mumps-rubella vaccination with other childhood schedule vaccines.
    Heath TC; Burgess MA; O'Brien ED
    Commun Dis Intell; 1998 Aug; 22(8):159. PubMed ID: 9735551
    [No Abstract]   [Full Text] [Related]  

  • 14. Present status of measles and rubella immunization in the United States: a medical progress report.
    Krugman S
    J Pediatr; 1977 Jan; 90(1):1-12. PubMed ID: 12253
    [No Abstract]   [Full Text] [Related]  

  • 15. Age-related changes in the rate of disease transmission: implications for the design of vaccination programmes.
    Anderson RM; May RM
    J Hyg (Lond); 1985 Jun; 94(3):365-436. PubMed ID: 4008922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward rubella elimination in Poland: need for supplemental immunization activities, enhanced surveillance, and further integration with measles elimination efforts.
    Zimmerman L; Rogalska J; Wannemuehler KA; Haponiuk M; Kosek A; Pauch E; Plonska E; Veltze D; Czarkowski MP; Buddh N; Reef S; Stefanoff P
    J Infect Dis; 2011 Jul; 204 Suppl 1():S389-95. PubMed ID: 21666189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measles, rubella, and congenital rubella syndrome--United States and Mexico, 1997-1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Nov; 49(46):1048-50, 1059. PubMed ID: 11105768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP).
    McLean HQ; Fiebelkorn AP; Temte JL; Wallace GS;
    MMWR Recomm Rep; 2013 Jun; 62(RR-04):1-34. PubMed ID: 23760231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Indications for possibilities of preventive vaccination against measles and rubella].
    Siegert R
    Internist (Berl); 1971 Aug; 12(8):309-12. PubMed ID: 4936452
    [No Abstract]   [Full Text] [Related]  

  • 20. [Certain problems with limits of immunity against measles, mumps and rubella].
    Magdzik W
    Przegl Epidemiol; 1993; 47(1-2):47-53. PubMed ID: 8351387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.